Anti-GM3 Monoclonal Antibody1vial

2,3-Difluorobenzeneboronic acid, 97.0%, 1g

4-bromo-6-nitro-1H-1,3-benzodiazole, 98%, 250mg

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[3,2-b]pyridine, 95.0%, 1g

METHYL 3-BROMOPYRAZOLO[1,5-A]PYRIMIDINE-6-CARBOXYLATE, 95.0%, 5g

tert-Butyl hexahydro-1H-pyrrolo[3,4-c]pyridine-2(3H)-carboxylate hydrochloride, 95.0%, 250mg

2-Bromo-5,6-dihydro-8H-imidazo[2,1-c][1,4]oxazine, 97%, 100mg

1,9-Dicyanononane, 98+%, 25g

2-(3-tert-Butyl-phenoxy)-N-hydroxy-acetamidine, 95.0%, 1g

6-Chloro-5-methylpyridin-2-amine, 95.0%, 5g

3-BROMO-5-(1,1-DIFLUOROETHYL)PYRIDINE, 95.0%, 10g

(2E)-3-(1-BENZOFURAN-2-YL)ACRYLIC ACID, 95.0%, 100mg

Quinoline-8-carboxamide, 97%, 1g